Literature DB >> 28892891

Distribution of Class D Carbapenemase and Extended-Spectrum β-Lactamase Genes among Acinetobacter Baumannii Isolated from Burn Wound and Ventilator Associated Pneumonia Infections.

Maryam Mohammadi1, Setareh Soroush2, Somayeh Delfani2, Iraj Pakzad1, Abolfazl Abbaszadeh3, Mahmoud Bahmani4, Lidija Bogdanovic5, Morovat Taherikalani2.   

Abstract

INTRODUCTION: Resistance to Acinetobacter baumannii is dramatically on the rise in Iran. Therefore, it is important to study resistance pattern among Acinetobacter isolates which is a common cause of nosocomial infections. AIM: To investigate antibiotic resistance patterns and the role of resistant genes and biofilm formation in the induction of resistance among Acinetobacter baumannii isolated from burn wound and ventilator associated pneumonia infections.
MATERIALS AND METHODS: Total 103 isolates such as 33 burn samples from Rasool Akram Hospital and 70 isolates from ventilated patients in Shahid Motahhari Hospital were identified with A. baumannii using biochemical method, and then identified to species level with PCR of gyrB and blaOXA-51 gene. Antibiotic sensitivity pattern for β-lactam and carbapenem antibiotics was assessed using Agar disc diffusion test and E-test. The presence of different carbapenemase and metalo-β-lactamase (blaOXA-51-like, gyrB, blaOXA-23-like, blaOXA-24-like, blaOXA-58, blaVEB, blaPER, blaGIM, blaSIM, blaIMP, blaVIM), extended-spectrum β-lactamases (blaTEM, blaSHV) and two insertion sequences genes (ISaba1, IS1113) was assessed. Biofilm formation of all isolates was then assessed. Chi-square analysis or Fisher's-exact tests were used for statistical analysis. A p-value <0.05 was considered statistically significant.
RESULTS: Colistin was the most effective antimicrobial agents, although 10.7% (11/103) of the isolates were resistant. The high rate of resistance to meropenem (93.2%) and imipenem (90.3%) was determined. Also, with exception of ampicillin-sulbactam, surprisingly the resistant rate was 28.2%, the resistance to β-lactam antibiotic was dramatically increased. Co-existence of two and three blaOXA genes was also determined. The blaOXA-58 was detected in only one isolate. The blaTEM and blaOXA-23 was the most prevalent Extended-Spectrum β-Lactamases (ESBL) gene. All isolates were biofilm producers.
CONCLUSION: Antibiotic resistance is increasing among A. baumannii isolates which is due to excessive use of antibiotics and also acquired resistant genes and biofilm production. Resistance to nearly all antimicrobial agents especially colistin as end choice for treatment of multiple drug resistance A. baumannii is a big concern.

Entities:  

Keywords:  Insertion elements; Nosocomial infections; β–lactams

Year:  2017        PMID: 28892891      PMCID: PMC5583823          DOI: 10.7860/JCDR/2017/25534.10218

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  33 in total

1.  Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.

Authors:  Yi-Tzu Lee; Chang-Phone Fung; Fu-Der Wang; Chien-Pei Chen; Te-Li Chen; Wen-Long Cho
Journal:  J Microbiol Immunol Infect       Date:  2011-12-14       Impact factor: 4.399

2.  Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.

Authors:  Morovat Taherikalani; Taherikalani Morovat; Bahram Fatolahzadeh; Fatolahzadeh Bahram; Mohammad Emaneini; Emaneini Mohammad; Setareh Soroush; Soroush Setareh; Mohamad Mehdi Feizabadi; Feizabadi Mohamad Mehdi
Journal:  New Microbiol       Date:  2009-07       Impact factor: 2.479

3.  Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates.

Authors:  Esther Zander; Alexandr Nemec; Harald Seifert; Paul G Higgins
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

4.  Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents.

Authors:  Y Carmeli; N Troillet; G M Eliopoulos; M H Samore
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.

Authors:  Nasrollah Sohrabi; Safar Farajnia; Mohammad Taghi Akhi; Mohammad Reza Nahaei; Behrooz Naghili; Amir Peymani; Zohreh Amiri; Mohammad Ahangarzadeh Rezaee; Nazli Saeedi
Journal:  Microb Drug Resist       Date:  2012-02-21       Impact factor: 3.431

6.  Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.

Authors:  Rodrigo E Mendes; Jan M Bell; John D Turnidge; Mariana Castanheira; Ronald N Jones
Journal:  J Antimicrob Chemother       Date:  2008-10-27       Impact factor: 5.790

7.  Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.

Authors:  David Landman; John M Quale; David Mayorga; Adedeyo Adedeji; Kalyani Vangala; Jayshree Ravishankar; Carlos Flores; Steven Brooks
Journal:  Arch Intern Med       Date:  2002-07-08

8.  Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii.

Authors:  R Srinivasa Rao; R Uma Karthika; S P Singh; P Shashikala; R Kanungo; S Jayachandran; K Prashanth
Journal:  Indian J Med Microbiol       Date:  2008 Oct-Dec       Impact factor: 0.985

9.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

10.  Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA.

Authors:  Vijaya B Srinivasan; Govindan Rajamohan; Preeti Pancholi; Kurt Stevenson; Daniel Tadesse; Prapas Patchanee; Mario Marcon; Wondwossen A Gebreyes
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-17       Impact factor: 3.944

View more
  2 in total

Review 1.  The threat of carbapenem-resistant gram-negative bacteria in a Middle East region.

Authors:  Effat Davoudi-Monfared; Hossein Khalili
Journal:  Infect Drug Resist       Date:  2018-10-17       Impact factor: 4.003

Review 2.  Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections.

Authors:  Matthew W McCarthy
Journal:  Drugs R D       Date:  2022-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.